GI-View is a medical device company revolutionizing the GI endoscopy market. The company has ongoing development programs for a full set of single-use GI endoscopes, including a colonoscope, gastroscope and pediatric scope.
Safer, More Hygienic and More Cost-Effective Colonoscopy
The Aer-O-Scope Colonoscope, is a single use colonoscope that addresses the growing demand for single use endoscopes to reduce disease transmission, lower operating costs and comply with changing endoscopic hygiene guidelines. The Aer-O-Scope’s novel optical system incorporates a highly sophisticated system that maximizes visualization, delivering wide-angle 200° panoramic visualization versus 140° of conventional multi-use scopes. And as camera technology constantly improves, using the Aer-O-Scope single-use solution provides clinics and hospitals a pathway to the most advanced visualizing technologies available without the need for capital equipment costs. The Aero-O-Scope system is currently in an advanced clinical trial.
Strong Financial Foundation
GI-View is a privately held company with investments by leading venture capital and equity funds, including Israel Healthcare Ventures Ltd., Ziegler Meditech Equity Partners, Shanghai Creation Investments, Kemper Insurance and a group of leading Israeli angel investors including Avigdor Willenz, Zvi Limon and Danny Tocatly.
The company is headquartered in Ramat Gan, Israel.